$38.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

MRNY was created on 2023-10-23 by YieldMax. The fund's investment portfolio concentrates primarily on health care equity. MRNY seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options.
Company

YieldMax

Asset class

Equity

Inception date

2023

Investment segment

Health Care

ISIN

US88636X2036

Key stats

Open

$37.86

Volume

482.68K

AUM

$254.02M

Prev. close

$39.09

Expense ratio

1.00%

P/E

0.00

$34.77

Day’s Range

$39.29

$14.01

52W Range

$47.94

What’s in the fund

20
Total holdings
Mrna 11/20/2026 135.01 C
55.58%
United States Treasury Bills 0%
18.71%
United States Treasury Notes 3.38%
11.63%
United States Treasury Notes 2.38%
9.76%
United States Treasury Bills 0%
9.60%
US DOLLARS
7.58%
MRNA US 10/23/26 C235
3.33%
United States Treasury Bills 0%
1.94%
Cash Offset
1.20%
Others
-19.33%

Returns

Performance
_
Difference
_
YieldMax MRNA Option Income Strategy ETF

Oct

23

Dividends

The last payment date was Oct 23, 2026

Div. per Share

$3.19

Div. Yield

8.16%

Div. Growth YoY

-44.09%

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply